Tumala, Apolinaria A.
HRN: 26-76-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/17/2025
03/24/2025
IVT
4.5g
Q8
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes